FDA Approves Generic Drug for Multiple Sclerosis

FDA Approves Generic Drug for Multiple Sclerosis

This week, the Food and Drug Administration approved the first generic substitute for Copaxone, a drug widely used to treat multiple sclerosis. Sandoz and Momenta Pharmaceuticals, the developers of the generic, have yet to announce prices for the drug. There are currently about 10 drugs used to treat multiple sclerosis, but this would the first generic that could be widely used. [4/20/15]

Search